Business
10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders
SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams inve
About this update from Bionano Genomics, Inc.
[{"type":"image","alt":"Bionano Genomics","displaySize":"","headline":null,"caption":"Bionano Genomics","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":61,"url":"https://media.zenfs.com/en/globenewswire.com/b39fec01655bcf34db9e215be03042b1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ylN8_Gs3_qAPxed5dOQIGw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTg1O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/b39fec01655bcf34db9e215be03042b1","width":300,"height":61}},"lazy":false},{"type":"text","content":"SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow based on the unbiased, genome-wide approach of optical genome mapping (OGM) particularly useful. Attendance at Symposium 2026 has grown to more than 1,200 participants from over 73 countries, with Day 3’s presentations coming from Japan, India, Brazil, the Netherlands, Turkey, and the United States, while the online poster hall now features 50 posters.","length":1144,"tagName":"p"},{"type":"text","content":"Alka Chaubey, PhD, FACMG, Bionano’s chief medical officer, opened the session by emphasizing the power of OGM to deliver unbiased, comprehensive, genome-wide structural variant (SV) detection. She highlighted how OGM can provide positional context for interpreting complex rearrangements. Dr. Chaubey also noted the rapid growth in OGM publications and demonstrated how VIATM software can facilitate interpretation, turning complex structural variants into insights, helping to standardize workflows and uncover previously hidden genomic information.","length":550,"tagName":"p"},{"type":"text","content":"Among the key scientific highlights:","len...